VelaVigo
PrivateLast Round
VC Round
Jul 28, 2025
Total Funding Raised
$100M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
VelaVigo is a biopharmaceutical company that specializes in the discovery and development of multispecific antibodies and antibody-drug conjugates for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VelaVigo Comparables
Compare VelaVigo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 90% | |
| Duality Biotherapeutics Inc | 82% | |
| BioNTech SE | 79% |
VelaVigo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 28, 2025 | ||||
| Pre Seed | Dec 31, 2024 | ||||
| Angel | Nov 15, 2021 |
Key People
Founding team and executive leadership
VelaVigo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | VC Round, Pre Seed, Angel |
| Legend Star | VC Round, Pre Seed |
| Shanghai Healthcare Capital | VC Round, Pre Seed |
| Zoo Capital | VC Round, Pre Seed |
| Highlight Capital | VC Round, Pre Seed |
| Northern Light Venture Capital | VC Round |
| Delian Capital | VC Round, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Dec 5, 2025
Monthly visitors grew 1573% MoM, from 113 to 1.9K.
VelaVigo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VelaVigo's valuation, stock price, and market status.
Is VelaVigo a public or private company?
VelaVigo is a private company.
What is the current stock price of VelaVigo?
VelaVigo is a private company with no public stock price. No recent secondary market data is available.
How much is VelaVigo worth (valuation)?
Valuation information for VelaVigo is not publicly available.
Can I buy VelaVigo stock?
VelaVigo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VelaVigo's last funding round?
VelaVigo's most recent funding round was Early Funding on July 28, 2025.
Who are the main investors in VelaVigo?
Key investors in VelaVigo include Shanghai Healthcare Capital, Shunwei Capital.
Will VelaVigo IPO soon?
No public IPO plans have been announced for VelaVigo.
How can I track VelaVigo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VelaVigo's secondary market activity and sign up for updates.